In the News
Vitamin D Deficiency Prevalent, Minimum Recommended Dose
Tuesday, October 2, 2007
By Em Brown
HONOLULU, HI — Responses to vitamin D supplements vary among individuals, so clinicians need to monitor serum levels of 25 hydroxyvitamin D (25[OH]D) levels and evaluate monthly patterns, especially among patients who are vitamin D deficient. Epidemiological studies have shown that more than a third of the American population has vitamin and calcium deficiency.… continue reading
Mothers, babies need more vitamin D, say experts
Tuesday, October 2, 2007
TheStar.com
A new statement by the Canadian Paediatric Society says Canadian mothers and babies aren’t getting enough vitamin D. The society is particularly concerned about the prevalence of vitamin D deficiency in pregnant women, exclusively breastfed infants and northern aboriginal populations.… continue reading
AAD MILKING ANTI-TANNING PRESS
Tuesday, October 2, 2007
The American Academy of Dermatology is milking anti-tanning press reports about federal legislation passed last week asking the U.S. Food and Drug Administration to investigate the effectiveness of warning language on indoor tanning equipment. “The Tanning Accountability Act” — promoted since last spring by New York Rep.… continue reading
What Is The Verdict On The Health Benefits Of Vitamin D?
Monday, October 1, 2007
CityNews.ca Staff
Vitamin D is good for your bones. Enough Vitamin D can help prevent cancer. Too much Vitamin D causes cancer. Vitamin D can help you win the lottery! O.K., that last one is a bit much, but the way some recent studies tell it, the so-called “Sunshine Vitamin” is capable of some wondrous effects.… continue reading
Arthritis drugs tied to skin cancer
Thursday, September 27, 2007
Rheumatoid arthritis patients on Remicade, Humira or Enbrel have a small but higher risk of skin cancer, a National Data Bank for Rheumatic Diseases study concludes. The new study contradicts earlier findings that the drugs raise patients’ risk of solid tumor, but supports earlier findings linking the new TNF blocker drugs to skin cancers, including melanomas.… continue reading
